Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients

Published:2018-10-03 Issue:1 Volume:6 Page:
ISSN:2051-1426
Container-title:Journal for ImmunoTherapy of Cancer
language:en
Short-container-title:j. immunotherapy cancer

Author:

Zhao Bin,Zhao Hong,Zhao Jiaxin

Funder

National Natural Science Foundation of China

Natural science foundation of heilongjiang province

Natural science foundation of heilonjiang province

health and family planning commission foundation of heilonjiang provine

start-up foundation of Harbin medical university

Publisher

BMJ

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1186/s40425-018-0421-z.pdf

Reference36 articles.

1. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–74.

2. Sun C, Mezzadra R, Schumacher TN. Regulation and function of the PD-L1 checkpoint. Immunity. 2018;48(3):434–52.

3. Ribas A, Wolchok JD. Cancer immunotherapy using checkpoint blockade. Science. 2018;359(6382):1350–5.

4. Hoffmann TC, Del Mar C. Patients' expectations of the benefits and harms of treatments, screening, and tests: a systematic review. JAMA Intern Med. 2015;175(2):274–86.

5. Zhang S, Liang F, Li W, Wang Q. Risk of treatment-related mortality in cancer patients treated with ipilimumab: a systematic review and meta-analysis. Eur J Cancer. 2017;83:71–9.

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of target agent treatment strategies for platinum-resistant recurrent ovarian cancer: A Bayesian network meta-analysis;Medicine;2024-05-24

2. Lymphatic expression of the proliferation marker Ki67 is linked to sentinel node positivity, recurrence and mortality in primary cutaneous melanoma;Experimental Dermatology;2024-03

3. Opioid analgesics for nociceptive cancer pain: A comprehensive review;CA: A Cancer Journal for Clinicians;2023-12-18

4. Nivolumab Safety in Renal Cell Carcinoma: A Case Report;Journal of Pharmacy Technology;2023-12-15

5. Depression and anxiety in cancer patient enrolled in clinical trials with serious adverse events;Cancer Medicine;2023-09-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3